Hôpital Européen Marseille
Clinical trials sponsored by Hôpital Européen Marseille, explained in plain language.
-
Can a simple glue stop Post-Surgery fluid pockets in breast cancer patients?
Symptom relief CompletedThis study tested whether a surgical glue called Ifabond can reduce seroma—painful fluid collections—after breast cancer surgery. 104 women having partial mastectomy with or without lymph node removal were randomly assigned to receive standard surgery plus the glue or standard su…
Phase: NA • Sponsor: Hôpital Européen Marseille • Aim: Symptom relief
Last updated Jun 23, 2026 12:08 UTC
-
Two-Minute sweat test spots nerve damage in autoimmune patients
Knowledge-focused CompletedThis study tested a fast, non-invasive device called SUDOSCAN to detect small fiber neuropathy (nerve damage) in 139 adults with autoimmune diseases (like lupus or rheumatoid arthritis) or unexplained pain. The goal was to see how common this nerve damage is in these groups. The …
Phase: NA • Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
New french questionnaires aim to better diagnose dizziness and detachment disorders
Knowledge-focused CompletedThis study tested French versions of two questionnaires: one measures feelings of detachment from oneself (depersonalization), and the other helps diagnose a chronic dizziness condition called PPPD. Researchers enrolled 612 adults with and without balance disorders to ensure the …
Phase: NA • Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
Gut bacteria linked to brain and bowel diseases in small study
Knowledge-focused CompletedThis study looked at gut bacteria in 15 people with inflammatory bowel disease (IBD) or Parkinson's disease, comparing them to healthy individuals. Researchers analyzed stool and blood samples to see which bacteria were present and whether bacteria were leaking from the gut into …
Phase: NA • Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 03, 2026 12:03 UTC